Emerald Health Therapeutics Inc (EMH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 42 | 41 | 34 | 32 | 32 |
| Accounts receivable | -54 | -53 | -5 | -2 | 13 |
| Accounts payable and accrued liabilities | -171 | 228 | 171 | -38 | 41 |
| Other Working Capital | -358 | 83 | 13 | -35 | 96 |
| Other Operating Activity | -1,055 | -1,224 | -863 | -478 | -590 |
| Operating Cash Flow | $-1,596 | $-924 | $-649 | $-521 | $-408 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -432 | -106 | 32 | -29 | -89 |
| Other Investing Activity | -2,008 | 0 | -62 | 0 | 0 |
| Investing Cash Flow | $-2,440 | $-106 | $-30 | $-29 | $-89 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 0 | -185 | 544 | 506 |
| Common Stock Issued | 27,123 | 13,817 | 3,000 | 836 | N/A |
| Other Financing Activity | -1,681 | -1,251 | 206 | 34 | -7 |
| Financing Cash Flow | $25,442 | $12,567 | $3,021 | $1,414 | $499 |
| Beginning Cash Position | 14,753 | 3,217 | 875 | 11 | 9 |
| End Cash Position | 36,160 | 14,753 | 3,217 | 875 | 11 |
| Net Cash Flow | $21,407 | $11,536 | $2,342 | $865 | $2 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,596 | -924 | -649 | -521 | -408 |
| Capital Expenditure | -432 | -106 | -31 | -29 | -89 |
| Free Cash Flow | -2,028 | -1,030 | -680 | -549 | -497 |